丁香通
学术直播
仪器库
丁香园
论坛
医药招聘
丁香医生
更多
调查派
用药助手
丁香搜索
医药数据库
丁香医考
我要登录
|
免费注册
|
我的丁香通
企业机构:
成为企业机构
个人用户:
个人中心
移动端
搜文献
大家都在搜
大家都在搜
0 人通过求购买到了急需的产品
免费发布求购
搜索
发布求购
全部产品分类
首页
仪器库
试用中心
实验专区
文献找产品
最新资讯
品牌活动
企业库
品牌库
首页
>
CiteLab
>
CANCER CELL
CANCER CELL
简称
CANCER CELL
新锐分类
医学
JCR分类
细胞生物学、肿瘤学
ISSN
1535-6108
EISSN
1878-3686
出版商
CELL PRESS
新锐分区
1 区
2025 JIF
56.1
JIF分区
Q1
简介
《Cancer Cell》是Cell Press出版的癌症细胞,创刊于2002年,是肿瘤学领域顶级期刊。期刊位列JCR Q1区和中科院1区Top,影响因子超过50,涵盖肿瘤突破性研究。
最新文献
KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer.
PMID: 42956743
2026-10-29
A sex-specific platelet switch controls anti-tumor immunity in glioblastoma.
PMID: 42956742
2026-10-29
Intrinsic resistance to KRAS inhibition: Interfering with interferon.
PMID: 42956741
2026-10-29
CPS + EG and Neo-Bioscore predict individual outcomes but not trial results after neoadjuvant therapy for early breast cancer.
PMID: 42945961
2026-10-27
Antibiotics and outcomes of cancer immunotherapy: An updated meta-analysis and clinical applications.
PMID: 42945960
2026-10-27
Macrophage lipid signaling drives glioblastoma invasion and represents a therapeutic vulnerability.
PMID: 42945959
2026-10-27
Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab.
PMID: 42913635
2026-10-22
How far are we from multi-omics states to therapeutic targets in microsatellite-stable colorectal cancer?
PMID: 42913634
2026-10-22
Multiomic characterization of microsatellite-stable colorectal cancer reveals distinct biology and targetable vulnerabilities.
PMID: 42913633
2026-10-22
The neoantigen quality model: Is closer to self more non-self?
PMID: 42913632
2026-10-22
Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.
PMID: 42896549
2026-10-19
Firmonertinib in advanced non-small cell lung cancer with epidermal growth factor receptor P-loop and αC-helix compressing mutations.
PMID: 42887497
2026-10-16
One structural class, one treatment? Firmonertinib in PACC-mutant NSCLC.
PMID: 42887496
2026-10-16
Hitting KRAS G12D without the gut punch: Can immunotherapy make it last?
PMID: 42863460
2026-10-12
Toward the next generation of CAR T cell therapies for cancer.
PMID: 42863461
2026-10-12
Microbial cues for a stem-like lymphoid niche.
PMID: 42863459
2026-10-12
Chemotherapy enhances cancer vaccine efficacy and expands stem-like TCF1+CD8+ T cells.
PMID: 42826713
2026-10-12
Beyond BMI: The diet-microbiome context of the obesity paradox.
PMID: 42815460
2026-10-12
The wu wei of brain metastases: When the gift of a pause is also a vulnerability.
PMID: 42805171
2026-10-12
A transient MXD4-dependent proliferative pause enables survival of brain micrometastases.
PMID: 42805170
2026-10-12
上一页
1
2
3
4
5
•••
209
下一页